[1] [2] It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking a naturally occurring hormone that regulates appetite and food intake
To overcome these limitations, a number of pharmacological approaches have been developed over the past decades, but these drugs are generally of fairly limited efficacy, expensive and can in some cases cause significant side effects
Clinical trial data supporting FDA approval included studies extending up to 68 weeks (approximately 16 months), with extension studies following participants for up to two years
Weeks 2 through 4: settling in Continue at 0.25 mg weekly
What to watch for: The dose increase from 0.5 to 1.0 mg is the largest percentage jump in the protocol (100% increase)
When caused by telogen effluvium, hair shedding typically lasts for 6 to 9 months